Search Results

The Real-Time PCR Internal Control 2B Set consists of reagents intended for use as an unassayed internal extraction and amplification process control in any real-time polymerase chain reaction (PCR) assay. The Internal Control 2B Set can be used to detect systemic variation that may arise during the extraction and amplification process associated with real-time PCR assays. The set is not intended to monitor other real-time PCR processes.

Not Found

The provided document is a 510(k) premarket notification letter from the FDA to Nanogen, Inc. regarding their Real-Time PCR Internal Control 2B Set. This document does not contain information about acceptance criteria, study details, or performance data of the device.

The letter states that the FDA has reviewed the 510(k) and determined the device is substantially equivalent to legally marketed predicate devices. It discusses regulatory classifications, general controls, and other requirements under the Federal Food, Drug, and Cosmetic Act. The "Indication for Use" section describes the intended purpose of the device as an unassayed internal extraction and amplification process control in real-time PCR assays.

Since the provided text is a regulatory clearance letter and not a study report or a detailed submission, it lacks the specific information requested in your prompt regarding acceptance criteria and device performance studies. Therefore, I cannot provide the requested table or answer the specific questions about sample sizes, ground truth establishment, expert qualifications, or multi-reader studies.

Ask a specific question about this device